Improving flap survival by transplantation of a VEGF-secreting endothelised scaffold during distal pedicle flap creation

被引:18
作者
Lasso, J. M.
Del Rio, M.
Garcia, M.
Martinez Calleja, V.
Nava, P.
Munoz-Fernandez, M. A.
Perez Cano, R.
机构
[1] Hosp Gen Univ Gregorio Maranon, Serv Cirugia Plast & Reparadora, Madrid 28007, Spain
[2] Hosp Gen Univ Gregorio Maranon, Lab Inmunobiol Mol, Madrid, Spain
[3] CIEMAT, Epithelial Damage Repair & Tissue Engn Project, E-28039 Madrid, Spain
[4] Hosp Valdecilla, Serv Farmacol, Santander, Spain
关键词
adenovirus; VEGF; gene therapy; angiogenesis; flaps;
D O I
10.1016/j.bjps.2006.04.002
中图分类号
R61 [外科手术学];
学科分类号
摘要
The benefits of a VEGF-secreting endothelised scaffold on the survival of distal flaps with early pedicle flap division were evaluated in a rabbit model. We bioengineered a scaffold based on a fibrin matrix in which endothelial cells, genetically modified with a VEGF-encoding adenoviral vector were embedded. We distributed subjects in four groups. Control: Eight rabbits conditioned with endothetial cells embedded in a fibrin scaffold. The pedicte was divided after a period of 5 days; and eight rabbits conditioned with endothetial cells embedded in a fibrin scaffold but in this group the pedicle was divided after a period of 2 days. Treatment: Eight rabbits conditioned with VEGF-secreting endothelial cells embedded in a fibrin scaffold; the pedicte was divided after a period of 5 days. And eight rabbits conditioned with VEGF-secreting endothetial cells but the pedicte was divided after a period of 2 days. The percentages of survival were 95.62 +/- 4.95% for the VEGF-producing scaffold vs. 51.25 +/- 45.88% for a non-VEGF secreting scaffold when sectioning the pedicle after 5 days. The percentage of survival of flaps in the group grafted with the VEGF-secreting scaffold was 55.62% compared to 2.5% in the group receiving the non-VEGF scaffold when the pedicle was sectioned after 2 days. The CD 31 immunostaining studies showed a dramatic increase in angiogenesis in the flaps conditioned by the VEGF producing scaffolds. These data revealed that endothelised VEGF-secreting scaffold during flap creation could be a suitable approach in reconstructive surgery. (c) 2007 The British Association of Plastic Surgeons. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:279 / 286
页数:8
相关论文
共 39 条
[1]
Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues [J].
Akagi, K ;
Ikeda, Y ;
Miyazaki, M ;
Abe, T ;
Kinoshita, J ;
Maehara, Y ;
Sugimachi, K .
BRITISH JOURNAL OF CANCER, 2000, 83 (07) :887-891
[2]
Vasodilator effect and mechanism of action of vascular endothelial growth factor in skin vasculature [J].
Ashrafpour, H ;
Huang, N ;
Neligan, PC ;
Forrest, CR ;
Addison, PD ;
Moses, MA ;
Levine, RH ;
Pang, CY .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2004, 286 (03) :H946-H954
[3]
Improved perfusion after subcritical ischemia in muscle flaps treated with vascular endothelial growth factor [J].
Banbury, J ;
Siemionow, M ;
Porvasnik, S ;
Petras, S ;
Browne, E .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2000, 106 (07) :1541-1546
[4]
Davis R E, 1999, Arch Facial Plast Surg, V1, P27, DOI 10.1001/archfaci.1.1.27
[5]
Nonviral transfer of genes to pig primary keratinocytes. Induction of angiogenesis by composite grafts of modified keratinocytes overexpressing VEGF driven by a keratin promoter [J].
Del Rio, M ;
Larcher, F ;
Meana, A ;
Segovia, JC ;
Alvarez, A ;
Jorcano, JL .
GENE THERAPY, 1999, 6 (10) :1734-1741
[6]
Antiproliferative effects of PCA-4230, a new antithrombotic drug, in vascular smooth muscle cells [J].
delRio, M ;
Sunkel, C ;
Larcher, F ;
Ortega, MP .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 120 (07) :1360-1366
[7]
HORN DB, 1998, LARYNGOSCOPE, V98, P521
[8]
BASIC FIBROBLAST GROWTH-FACTOR HAS A BENEFICIAL EFFECT ON THE VIABILITY OF RANDOM SKIN FLAPS IN RATS [J].
ISHIGURO, N ;
YABE, Y ;
SHIMIZU, T ;
IWATA, H ;
MIURA, T .
ANNALS OF PLASTIC SURGERY, 1994, 32 (04) :356-360
[9]
Clinical evidence of angiogenesis after arterial gene transfer of phVEGF(165) in patient with ischaemic limb [J].
Isner, JM ;
Pieczek, A ;
Schainfeld, R ;
Blair, R ;
Haley, L ;
Asahara, T ;
Rosenfield, K ;
Razvi, S ;
Walsh, E ;
Symes, JF .
LANCET, 1996, 348 (9024) :370-374
[10]
The effects of VEGF on survival of a random flap in the rat: examination of various routes of administration [J].
Kryger, Z ;
Zhang, F ;
Dogan, T ;
Cheng, C ;
Lineaweaver, WC ;
Buncke, HJ .
BRITISH JOURNAL OF PLASTIC SURGERY, 2000, 53 (03) :234-239